MMS Holdings Expert Insights Blog

Experts at MMS share their insights on trending
topics in the pharmaceutical industry.

FDA Furthers Transparency Push with CSR Release Pilot

FDA Furthers Transparency Push with CSR Release Pilot

The FDA provided insight into their overall vision for clinical trial transparency last week, announcing a new program to publicly release clinical study reports (CSRs) that accompany drug approval submissions. They plan to pilot nine recently-approved drugs (yet to...

read more
Big Improvements in Clinical Trial Transparency Compliance

Big Improvements in Clinical Trial Transparency Compliance

Bioethics International recently published their second, long-promised Good Pharma Scorecard, a ranking of large biopharmaceutical companies’ compliance with disclosing data for new medicines to public registries, in BMJ Open. With this recent publication, a spotlight...

read more
MMS Gives Back: Flint Water Distribution

MMS Gives Back: Flint Water Distribution

In an effort to give back to our community, MMS colleagues worked with the American Red Cross to deliver water to our neighbors in Flint, Michigan. On Wednesday, March 9, the MMS team was able to deliver 190 cases of water and numerous water filters to over 140 homes....

read more
MMS Funds $1 Million Zika Vaccine Development Award

MMS Funds $1 Million Zika Vaccine Development Award

Canton, Mich. (March 14, 2016) — MMS Holdings Inc., a specialty data-focused CRO, has announced a $1M award toward the development of a Zika vaccine. The award is being offered as data services to qualified pharmaceutical companies supporting the commercial...

read more
MMS Logo
6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

LinkedIn LogoFacebook logoTwitter logoYoutube logo

CONNECT WITH US